Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden
Malin Hultcrantz(United States Fish and Wildlife Service), Therése Andersson(Karolinska Institutet), Jan Samuelsson(Karolinska University Hospital), Björn Andréasson(NU Hospital Group), Anna Ravn Landtblom(Karolinska University Hospital), Sigurður Y. Kristinsson(Reykjavík University), Paul W. Dickman(Karolinska Institutet), Magnus Björkholm(Karolinska Institutet)
Cited by 65
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
GPRC5D-Targeted CAR T Cells for Myeloma
|New England Journal of Medicine|2022|383